Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
Osteoporos Int
; 28(1): 389-398, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27631091
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteoporosis
/
Diphosphonates
/
Bone Density Conservation Agents
/
Imidazoles
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
En
Journal:
Osteoporos Int
Journal subject:
METABOLISMO
/
ORTOPEDIA
Year:
2017
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom